drugset
drugset / Trial / NCT05241431

Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention

NCT05241431 ↗

Phase 2/3 Unknown 106 enrolled University of Aarhus Aarhus University Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized, double-blinded, placebo-controlled study in AS patients with subclinical or clinical heart failure undergoing treatment with TAVR.

Timeline

Start
2022-02-12
Primary completion
2024-03-01
Completion
2024-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapagliflozin Small molecule 10 mg Oral

Indications

aortic valve stenosis intrinsic cardiomyopathy